Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 March 2023 | Story Jóhann Thormählen | Photo Supplied
Nomsa Mathontsi is a senior member of the Kovsie women’s football team and has played in two Varsity Football and three USSA tournaments.

Nomsa Mathontsi senior member of the University of the Free State (UFS) Women’s Football team has, despite enormous challenges excelled and achieved remarkable heights on and off the field.

Ms Mathontsi has been an avid sportsperson from an early age. Among her many extraordinary achievements the talented Ms Mathontsi has also been on the South African Women’s National Soccer squad Banyana Banyana.

What many may not know though, is that this is notwithstanding the obstacle Ms Mathontsi overcame in order to reach such heights. The Kovsie striker has limited hearing in her right ear and received a cochlear implant before she began her UFS journey in 2018.

I got affected when I was really young. I was doing athletics. This one time I had a very hectic race, which blocked my right ear –

At the University of the Free State Kovsie Health takes into account the medical history of its’ high-performance athletes who are closely monitored with the aim of achieving optimal performance. As in the case of Ms Mathonsi it is most important that the medical practitioner, Dr Gerhard Jansen, and his team at Kovsie Health take into consideration her medical history. 

Kovsie Health provides a range of services to the UFS football programme that include: medical screenings; injury diagnosis; treatment; and rehabilitation. 

Compulsory medicals

“I got affected when I was really young. I was doing athletics. This one time I had a very hectic race, which blocked my right ear.

“At first my family thought it was going to be OK, until we realised it was extremely serious and we had to do medicals,” the versatile player says.

Ms Mathontsi, a BAdmin student in Economic and Management Sciences has an implant in her skull but cannot play with her hearing device.

“Even the implant itself can be dangerous. If someone hits me with an elbow or something hard or (on the) head, it will hurt.”

It is compulsory for all UFS football players to take the South African Football Association medicals. Kovsie Health assists players in this process. This is conducted before each new season and include a basic medical, family and practice history, basis line tests, injury assessments etc.

According to Jansen, Kovsie Health needs to be aware of Mathontsi’s medical history so that they may make informed decisions and provide guidance. We will document it and if she should get concussion you will have to take it into account. We for instance know we shouldn’t see a loss of hearing as a negative sign.”

Special Kovsie football family

Mathontsi has represented the UFS in two Varsity Football campaigns, three USSA tournaments and plays in the Free State Sasol League.

Although she hasn’t made her international debut, she received two call-ups to the South African women’s squad and trained with Banyana Banyana.

The number 8 loves her UFS football family and says she has also learnt to balance sport and university.

“I think it is the bond and relationships we have with each other on and off the field that makes it special.

“I have learnt a lot in terms of leadership and how to take leadership as a senior player in the team.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept